Detecting Genetic Associations between ATG5 and Lupus Nephritis by trans-eQTL
Yue-Miao Zhang1, Fa-Juan Cheng2, Xu-Jie Zhou1
1Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China and Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Peking University, Ministry of Education, Beijing 100034, China.
This study identified 10 genetic loci potentially associated with lupus nephritis (LN) susceptibility in a Chinese population. These findings offer new insights into the genetic regulation of ATG5 expression in systemic lupus erythematosus (SLE).
Area of Science:
- Genetics
- Immunology
- Systemic Lupus Erythematosus Research
Background:
- Elevated ATG5 expression is linked to systemic lupus erythematosus (SLE).
- Understanding the genetic regulation of ATG5 is crucial for lupus nephritis (LN) research.
Purpose of the Study:
- To investigate genome-wide genetic regulatory mechanisms of ATG5 expression in a Chinese population with LN.
- To identify trans-expression single nucleotide polymorphisms (trans-eSNPs) associated with LN susceptibility.
Main Methods:
- Searched online databases for ATG5 trans-eSNPs.
- Genotyped tagging trans-eSNPs in 280 LN patients and 199 controls using a custom chip.
- Performed clinical and bioinformatic analyses on positive findings.
Main Results:
- Four trans-eSNPs (ANKRD50 rs17008504, AGA rs2271100, PAK7 rs6056923, TET2 rs1391441) showed significant association with LN susceptibility (P < 0.05).
- Seven additional trans-eSNPs exhibited marginal associations (0.05 < P < 0.1).
- Validated correlations between trans-eSNPs, ATG5 expression, and validated regulatory effects, but found no association with disease severity or outcome.
Conclusions:
- Identified 10 potential loci associated with LN susceptibility using a systemic genetics approach.
- These findings may complement future pathway-based genetic studies in SLE and LN.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets


